VB

Vijaya Babu Gandham

Active Director Director DIN 09101572
DIN 09101572 First appointment Mar 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Vijaya Babu Gandham

Data last updated:

Vijaya Babu Gandham is a Director at Sanux Laboratories Private Limited (since 2021). The company operates in Healthcare.

DIN 09101572
Primary Designation Director
Industry Healthcare
First Appointment 11 Mar 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sanux Laboratories Private Limited U24297AP2021PTC117649
Director11 Mar 20212021Active

Directorship timeline

Open interactive timeline →
Sanux Laboratories Private Limited
Premium access

Shareholding and investment profile for Vijaya Babu Gandham

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vijaya Babu Gandham

Vijaya Babu Gandham currently holds 1 directorship: Sanux Laboratories Private Limited (Director, since 11 Mar 2021).

Vijaya Babu Gandham was first appointed on 11 Mar 2021 as Director at Sanux Laboratories Private Limited.

The current boards of Vijaya Babu Gandham's companies include Gandham Nageswara Rao (Sanux Laboratories Private Limited), Rehana Begum Shaik (Sanux Laboratories Private Limited), Surya Subrahmanya Varma Vegesna (Sanux Laboratories Private Limited), Venkata Durga Raju Vegesna (Sanux Laboratories Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available